Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Nektar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NKTR.
You can purchase shares of Nektar Therapeutics (NASDAQ:NKTR) through any online brokerage.
Other companies in Nektar Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Cumberland (NASDAQ:CPIX), Bioage Labs (NASDAQ:BIOA) and Neumora Therapeutics (NASDAQ:NMRA).
Nektar Therapeutics has a consensus price target of $4.41.
The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $0.8577 last updated March 5, 2025 at 6:26 PM EST.
There are no upcoming dividends for Nektar Therapeutics.
Nektar Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Nektar Therapeutics.
Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.